G

Grand Pharmaceutical Group Ltd
HKEX:512

Watchlist Manager
Grand Pharmaceutical Group Ltd
HKEX:512
Watchlist
Price: 4.34 HKD -2.47% Market Closed
Market Cap: 15.2B HKD
Have any thoughts about
Grand Pharmaceutical Group Ltd?
Write Note

Grand Pharmaceutical Group Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Grand Pharmaceutical Group Ltd
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
G
Grand Pharmaceutical Group Ltd
HKEX:512
Net Income (Common)
HK$2.4B
CAGR 3-Years
2%
CAGR 5-Years
21%
CAGR 10-Years
34%
S
SSY Group Ltd
HKEX:2005
Net Income (Common)
HK$1.4B
CAGR 3-Years
29%
CAGR 5-Years
6%
CAGR 10-Years
11%
U
United Laboratories International Holdings Ltd
HKEX:3933
Net Income (Common)
ÂĄ2.9B
CAGR 3-Years
37%
CAGR 5-Years
27%
CAGR 10-Years
18%
Sino Biopharmaceutical Ltd
HKEX:1177
Net Income (Common)
ÂĄ4.1B
CAGR 3-Years
-26%
CAGR 5-Years
-15%
CAGR 10-Years
16%
C
China Resources Pharmaceutical Group Ltd
HKEX:3320
Net Income (Common)
HK$6.5B
CAGR 3-Years
27%
CAGR 5-Years
6%
CAGR 10-Years
N/A
H
HUTCHMED (China) Ltd
HKEX:13
Net Income (Common)
-$42m
CAGR 3-Years
38%
CAGR 5-Years
14%
CAGR 10-Years
N/A
No Stocks Found

Grand Pharmaceutical Group Ltd
Glance View

Market Cap
15.4B HKD
Industry
Pharmaceuticals

Grand Pharmaceutical Group Ltd. engages in the development, manufacture and distribution of pharmaceutical products. The firm is principally engaged in manufacturing and sales of pharmaceutical preparations and medical devices, bio-technology products, nutrition products, specialized pharmaceutical raw materials and other products. The main products of the Company cover the anti-tumor, cardiovascular emergency pharmaceutical products and advanced cerebro-cardiovascular intervention advanced medical devices, anti-virus and anti-infection, respiratory and ear-nose-throat (ENT), bio-health products and specialized pharmaceutical ingredients.

Intrinsic Value
6.32 HKD
Undervaluation 31%
Intrinsic Value
Price
G

See Also

What is Grand Pharmaceutical Group Ltd's Net Income (Common)?
Net Income (Common)
2.4B HKD

Based on the financial report for Jun 30, 2024, Grand Pharmaceutical Group Ltd's Net Income (Common) amounts to 2.4B HKD.

What is Grand Pharmaceutical Group Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
34%

Over the last year, the Net Income (Common) growth was 0%. The average annual Net Income (Common) growth rates for Grand Pharmaceutical Group Ltd have been 2% over the past three years , 21% over the past five years , and 34% over the past ten years .

Back to Top